Magic mushroom therapy tested for Cancer-Related depression
NCT ID NCT07216404
Summary
This study is testing whether psilocybin, the active compound in 'magic mushrooms,' combined with therapy, is safe and helpful for treating depression in people with non-small cell lung cancer. It involves 10 participants who will take a single dose of psilocybin during a guided therapy session. The main goals are to check for safety, see if patients find the treatment acceptable, and measure if it reduces depression and improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.